Genomics Science Group

Genomics Science Group as an Innovative Genetic and Genomics Company

Discover GSG

We'd like to make not just a tiny step, but a breakthrough into a new World! The World where DNA scientific research going to be based on Big Data, where it is possible to interpret the results of studies based on the research of the human genome much faster and easily, to integrate scientific discoveries into life as efficiently as possible.

learn more


GSG Computing Storage is a DNA digital storage solution, that allows research centers to solve the problem of enabling full-scale genome studies on a higher technological level with minimum costs.

GSG Computing Storage eliminates the necessity of research centers to build their own IT infrastructure to organize local storage.


Remastering Genomics with Blockchain & AI

background image

About GSG

Genomics Science Group is a new but aspiring genetic and genomics company that specialises in managing projects in the field of bioinformatics and computational genomics. The Company aims to provide technological capabilities for storing, processing, and analysing digital DNA samples for scientific and commercial research purposes.

Genomics Science Group was founded in 2018 by a group of international companies, that created an Open Foundation for managing capital-intensive innovative projects in the field of genomics.

GSG strategy envisages participation in research of human genome projects, that employs GSG Computing Storage for DNA digital samples.

Why Genomics?

Genomics, as a branch of molecular genetics, has an enormous scientific and commercial potential. First of all, the advancements in this field will let the humanity cope with the most dreadful diseases, that our species has been suffering from for ages, namely cancer, HIV, and many others.

Secondly, the knowledge acquired in the course of experimenting with genome is priceless in every imaginable way. For instance, many genetic drawbacks can potentially be corrected, and people will be able to evolve much quicker. Also, personal talents and interests could be realised through studying one’s genome. Thus a set of tips could be made as to what a person has the most chances to succeed in.

If we talk about the molecular physiology of a person, working with individual cells is something that is very important for understanding immunity. Because cells of the immune system are the cells in which genomic reorganisations occur, that is, they all possess some individuality, and then you can look at the changes that occurred in the individual cell. It is possible to compare the spectrum of these reorganisations in different people, to compare, what exactly adjustments have taken place in individual lymphocytes at different therapeutic influences, at allergies, because the allergy is actually a disease of one’s immune system.

In the future, it will be possible to understand what kind of adjustments lead to one or another allergy. We have invented the technology of fast and cheap determination of the sequence of nucleotides in DNA. But it turns out that these technologies germinate in classical biological disciplines: in embryology, immunology, cell biology, Oncology. They also greatly promote our understanding of the foundations of these sciences.

Valuable information on the role of genetic factors in a multitude of pathological conditions has already been obtained. The role of the clinical use of DNA based diagnostics is increasing. Genetic testing – Analysis of human nucleotide structures (DNA, RNA), as well as other biological structures, significant for clinical and genetic findings of gene disorders, phenotypes, etc. Genetic testing can have (and are already beginning to exert) a great impact on clinical practice (for example, in the treatment of such conditions as endocrine neoplasia, leukaemia, coronary atherosclerosis, etc.).

Genomics will have the most profound impact on medical thinking in general. The very idea of health and disease will experience (and, in general, already experiencing) influence on the part of genetic data. This will happen, despite the PA that the immaculate genomes do not happen. Each genome contains some defects (but accepted estimates, about 1 – 2%), so the notion of the genetic norm is vague. Nevertheless, with the expansion of the scope of genetic forecasts, the transition from more visible parameters is already starting today Health and pathology to latent, probabilistic factors.

The latest molecular genetics should also contribute to a substantial advancement in the resolution of the fundamental biomedical problem of individuality of the patient. The study of individual genomes should provide us with a platform for the development of specialised individual selection and prescription of medications. The new branch of Pharmacogenomics, which is now booming, with further improvement of methods of obtaining information about patients will open an era of truly individual pharmacology. Data pharmacogenomics today begin to enter into clinical practice for prediction of medicinal reactions in patients.

Finally, genomics is believed to be a passage not only to a longer life but also immortality. Of course, such a possibility is quite tempting, as humanity has always been looking for a possibility to live forever.

All the enlisted vectors comprise only a small part of the potential that genetic and genomic research contains. Having got inspired by all this, there occurred an idea to create a company that would help scientists collect, store, and process digital DNA samples, thus fastening the process of fulfilling these goals.


The mission of Genomics Science Group is to scale the practical application of genomics intended to improve the quality of life and extend the life of the human being. The main task of the Company is to build the largest digital storage for DNA samples of all organisms while maintaining its universality and democratising access to the general public, scientific and research centres.

How Are the Set Objectives Being Realized Today?

DNA sequencing requires vast computing and storing capabilities, as the volume of only one DNA sample equals several Gigabytes. Of course, DNA samples can be compressed to about 550 MBs, though to compress only one of them would require 2 hours of computer processing that has 6 GB RAM.

It goes without saying that to process, for instance, one million DNA sample, a lot of time will be needed. Thus, the question arises, how to fasten this process? That is where a distributed computing storage, GSG Computing Storage, that utilises blockchain technology comes into play.


GSG Computing Storage is a DNA digital storage “Big Data” class solution that allows research centres to solve the problem of enabling full-scale genome studies on a higher technological level with minimum costs. GSG Computing Storage eliminates the need for research centres to build their own IT infrastructure to maintain local storage.

With GSG Computing Storage Solution research centres gain access to the dedicated virtual DNA storage that they can manage and conduct research remotely.

The process of building of such storage started in March 2018 and will have been finished by mid-2019. Its distributed nature has several advantages over traditionally centralised storages of data. One of such strengths lies in computational capabilities that are considerably higher in distributed systems rather than in centralised ones. This can be explained by the fact that every task is spread between computing nodes that process and store encrypted information. Secondly, the use of blockchain ensures data safety thus eliminating the risk of its being accessed by third parties.

The advantages of utilising a distributed computing storage are obvious, and the process of its implementation will undergo several stages.

Stages of GSG Development

First, a virtual blockchain (VBC) was acquired, that allowed Genomics Science Group to build the desirable storage. And, in March 2018, the process was initiated, and now it is being prepared for widespread use. The stage is designed to finish the launch of GSG Computing storage, a digital DNA sample repository that allows research centres to conduct full-scale genome studies at a higher technology level with minimal cost. Research organisations have remote access to a dedicated virtual repository to store their own database of digital genome samples, processing and analysis.

Then, we intend to build a Biobank to store digital and physical samples of biological materials including DNA samples, tissue samples, etc. Such facility will provide scientific and research institution with constant access to the stored samples, for the sake of research of genes and related information. Such access is bound to make it easier to conduct further studies related to gene sequencing, and the overall impact on bioscience is estimated to be enormous. Moreover, the privacy of donors will be ensured, and people will be encouraged to share their biological material for research purposes.

By mid-2020, the Biobank, as well as the GSG Computing storage, will have been constructed meaning that the customers from scientific and commercial sectors will have an opportunity to utilise the capabilities proposed by these two constructions.

Potentially, natural persons will also have access to the services provided by GSG. They will be able to undertake DNA testing and, in case they consent, their results will be stored in the facilities above for further scientific research and testing.

Finally, when a sufficient number of samples are collected, they will be examined, and the acquired results will let scientists make certain advancements in the 3D printing of tissues and other biological constructions.


In the article, we have reviewed main fields and problems that Genomics Science Group is engaged in. Being a Company that operates in bioscience, GSG offers its services to scientific and research centres for various purposes. The two main products of GSG include Computing Storage and Biobank (that will be created). Both of them are repositories of biological materials, DNA, RNA, etc., though the first one deals with digital copies and the latter – with physical samples. These materials will be utilised during further research of human genes and their sequencing, as the advancements in the field of molecular genetics (i.e. genomics) have a potential not only to cure most of the dreadful diseases but also help humanity overcome death.

Our Partners

Thank you!
Thank you!
Thank you!